No abstract available
MeSH terms
-
3T3 Cells
-
Animals
-
Antibody Specificity
-
Benzimidazoles / chemistry
-
Benzimidazoles / pharmacology
-
Butadienes / chemistry
-
Butadienes / pharmacology
-
Cell Differentiation / drug effects
-
Drug Evaluation, Preclinical
-
Drug Stability
-
Enzyme Activation
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
Humans
-
In Vitro Techniques
-
K562 Cells
-
MAP Kinase Kinase 1
-
MAP Kinase Kinase 2
-
MAP Kinase Kinase Kinase 1*
-
Megakaryocytes / cytology
-
Megakaryocytes / drug effects
-
Mice
-
Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors*
-
Mitogen-Activated Protein Kinase Kinases / genetics
-
Mitogen-Activated Protein Kinase Kinases / metabolism
-
Mutation
-
Nitriles / chemistry
-
Nitriles / pharmacology
-
Phosphorylation
-
Protein Serine-Threonine Kinases / antagonists & inhibitors*
-
Protein Serine-Threonine Kinases / genetics
-
Protein Serine-Threonine Kinases / metabolism
-
Protein-Tyrosine Kinases / antagonists & inhibitors*
-
Protein-Tyrosine Kinases / genetics
-
Protein-Tyrosine Kinases / metabolism
-
Rats
-
Recombinant Proteins / antagonists & inhibitors
-
Recombinant Proteins / genetics
-
Recombinant Proteins / metabolism
-
Transfection
Substances
-
Benzimidazoles
-
Butadienes
-
Enzyme Inhibitors
-
Nitriles
-
PD 58491
-
Recombinant Proteins
-
U 0126
-
MAP2K2 protein, human
-
Protein-Tyrosine Kinases
-
Protein Serine-Threonine Kinases
-
MAP Kinase Kinase Kinase 1
-
MAP3K1 protein, human
-
Map3k1 protein, mouse
-
MAP Kinase Kinase 1
-
MAP Kinase Kinase 2
-
MAP2K1 protein, human
-
Map2k1 protein, mouse
-
Mitogen-Activated Protein Kinase Kinases